Ro-15-2041
98%
- Product Code: 230339
CAS:
77448-87-4
| Molecular Weight: | 294.15 g./mol | Molecular Formula: | C₁₂H₁₂BrN₃O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Ro-15-2041 is primarily used in scientific research as a selective antagonist for benzodiazepine binding sites on the GABAA receptor. It is employed to study the role of GABAergic neurotransmission in anxiety, memory, and sedation. Due to its ability to reverse the effects of benzodiazepines, it has been investigated for potential use in managing benzodiazepine overdose and tolerance. However, it remains an experimental compound and is not approved for clinical use. Its application is largely confined to preclinical studies in neuroscience and pharmacology.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿64,790.00 |
+
-
|
| 5mg | 10-20 days | ฿129,630.00 |
+
-
|
Ro-15-2041
Ro-15-2041 is primarily used in scientific research as a selective antagonist for benzodiazepine binding sites on the GABAA receptor. It is employed to study the role of GABAergic neurotransmission in anxiety, memory, and sedation. Due to its ability to reverse the effects of benzodiazepines, it has been investigated for potential use in managing benzodiazepine overdose and tolerance. However, it remains an experimental compound and is not approved for clinical use. Its application is largely confined to preclinical studies in neuroscience and pharmacology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :